Ingredion Incorporated

Ingredion Incorporated (INGR) Market Cap

Ingredion Incorporated has a market capitalization of $6.28B.

Price: $99.66

-0.32 (-0.32%)

Market Cap: 6.28B

NYSE · time unavailable

CEO: James Zallie

Sector: Consumer Defensive

Industry: Packaged Foods

IPO Date: 1997-12-11

Website: https://www.ingredion.com

Ingredion Incorporated (INGR) - Company Information

Market Cap: 6.28B|Sector: Consumer Defensive

Company Profile

Ingredion Incorporated, together with its subsidiaries, produces and sells starches and sweeteners for various industries. It operates through four segments: North America; South America; Asia-Pacific; and Europe, Middle East and Africa. The company offers sweetener products comprising glucose syrups, high maltose syrups, high fructose corn syrups, caramel colors, dextrose, polyols, maltodextrins, and glucose syrup solids, as well as food-grade and industrial starches, biomaterials, and nutrition ingredients. It also provides edible corn oil; refined corn oil to packers of cooking oil and to producers of margarine, salad dressings, shortening, mayonnaise, and other foods; and corn gluten feed used as protein feed for chickens, pet food, and aquaculture, as well as fruit and vegetable products, such as concentrates, purees and essences, pulse proteins, and hydrocolloids systems and blends. The company's products are derived primarily from processing corn and other starch-based materials, such as tapioca, potato, and rice. It serves food, beverage, brewing, and animal nutrition industries. The company was formerly known as Corn Products International, Inc. and changed its name to Ingredion Incorporated in June 2012. Ingredion Incorporated was founded in 1906 and is headquartered in Westchester, Illinois.

Analyst Sentiment

63%
Buy

From 21 Active Polls

1Y Forecast: $117.00

▲ +17.4% Potential Upside

Consensus Target Metrics

Low Bound

$114

Median

$117

High Bound

$120

Average

$117

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$117.00
▲ +17.40% Upside
Low Target
$114.00
14% Risk
Median Target
$117.00
17% Mid
High Target
$120.00
20% Max
Consensus
Hold
9 / 21 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)6,2847,1657,0137,8528,7478,7218,9698,9747,475
Enterprise Value ($M)7,1958,0767,7738,7359,6739,66810,0079,9378,820
Price to Earnings Ratio (P/E)9.4012.6110.6311.4811.1611.0723.6011.9312.63
Price/Earnings-to-Growth Ratio (PEG)6.3310.1115.32
Price to Sales Ratio (P/S)0.874.003.994.324.774.814.984.803.98
Price to Book Ratio (P/B)1.431.621.611.832.062.172.322.241.99
Price to Free Cash Flow Ratio (P/FCF)8.41-93.0525.9716.71104.14-581.4029.4120.9229.08
Enterprise Value to Sales (EV/Sales)4.514.424.815.285.335.565.314.70
Enterprise Value to EBITDA (EV/EBITDA)6.2131.5528.4728.6429.8629.2146.5430.3930.00
Debt to Equity Ratio0.790.410.410.420.420.440.530.460.49

INGR Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$99.66
Intrinsic Value$189.09
Market Alignment
Undervalued by 89.7%relative to calculated intrinsic value
9.00%
Exp: -1%-1%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.99B
Perpetuity TV Value$18.58B
Discounted TV (PV)$7.85B
TV Weighting %57.2%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 INGREDION INC (INGR) — Investment Overview

🧩 Business Model Overview

Ingredion is a business-to-business specialty ingredients company supplying food and beverage manufacturers, brewers, confectioners, and other industrial food users. The company converts agricultural commodities (primarily starch feedstocks and related inputs) into functional ingredient systems—such as starches, sweeteners, and nutrition-oriented specialties—that solve specific formulation needs. The value chain is “ingredient manufacturing + application support”:
  • Input sourcing & processing: raw materials are refined into intermediate and finished functional ingredients.
  • Formulation & technical development: Ingredion works with customers to engineer outcomes (taste, texture, processability, stability, shelf-life) rather than selling generic commodities.
  • Conversion to customer recipes: finished ingredients are integrated into customer production lines, creating operational dependency on validated specifications and process parameters.
  • Distribution & scale: global manufacturing footprint and logistics enable local supply and service levels for large multi-plant customers.

💰 Revenue Streams & Monetisation Model

Revenue is generated from selling functional ingredients into customer formulations. Monetisation is primarily driven by:
  • Ingredient mix: basic starches and commodity-adjacent products typically monetize through more competitive pricing, while specialty functional systems tend to support steadier margins through differentiated performance.
  • Application-driven repeat business: ingredient selections are sticky because performance must be validated in customer systems (quality specifications, processing parameters, and regulatory documentation).
  • Pass-through mechanics: pricing and contract terms often partially offset raw-material volatility through indexation and negotiated pricing frameworks.
  • Volume and utilization: manufacturing utilization and operational efficiency affect gross margin and leverage fixed costs.
Margin drivers to watch include: specialty mix and pricing discipline, conversion efficiency in manufacturing, and the degree to which commodity input movements are absorbed versus passed through.

🧠 Competitive Advantages & Market Positioning

Ingredion’s moat is best described as a combination of switching costs and application know-how, supported by scale and supply reliability.
  • High Switching Costs (Formulation & qualification): Customers qualify ingredients through sensory and processing trials, then lock parameters into production recipes and quality systems. Re-qualification can be time-consuming and costly, discouraging frequent supplier changes.
  • Intangible Asset: Application Development Capability—technical teams, ingredient performance data, and customer-specific solutioning improve outcomes beyond what undifferentiated product offerings can deliver.
  • Operational Scale & Supply Reliability: a manufacturing footprint supports service levels for multi-site customers, which matters in food supply chains where disruption risk is material.
Competitive benchmarking (selected peers):
  • Tate & Lyle: Strong in sweeteners and starch solutions, with a similar emphasis on functional differentiation. Ingredion competes through specialty capabilities and application support, while peer offerings often skew more heavily toward certain sweetener categories.
  • Cargill: More diversified across agricultural and food supply chains, including ingredient solutions. Cargill’s broad supply reach can support competitive pricing at times; Ingredion’s differentiation leans more on product functionality and customer-specific formulation systems rather than purely scale commodity positioning.
  • Archer Daniels Midland (ADM): Broad footprint with extensive capabilities in starches and sweeteners. ADM competes on scale and integration; Ingredion’s strategy emphasizes specialty functionality and customer stickiness to reduce sensitivity to pure commodity pricing.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by structural demand for functional and nutrition-oriented ingredients, along with industry conversion away from commodity-only products:
  • Shift toward higher-value functional ingredients: Food and beverage formulators seek improved texture, processability, stability, and labeling outcomes, sustaining demand for tailored starch and sweetener systems.
  • Nutrition and protein/health-forward applications: Demand for ingredient functionalities that support nutrition targets can broaden the addressable mix within the same end markets.
  • Regionalization of supply: Customers increasingly value locally supplied and reliably delivered inputs, supporting utilization and service-level advantages for firms with manufacturing reach.
  • Process optimization with customers: Ingredient systems that reduce process losses, improve yield, or extend shelf-life can win share even when category volumes are stable.

⚠ Risk Factors to Monitor

Key structural risks include:
  • Commodity and input volatility: Profitability can be pressured by movements in agricultural inputs, especially where pricing mechanisms do not fully offset cost changes.
  • Customer concentration and bargaining power: Large food customers can negotiate pricing and terms; switching costs reduce churn but do not eliminate periodic renegotiation.
  • Regulatory and labeling risk: Food regulations, quality standards, and changing dietary policy frameworks can affect product mix and demand patterns.
  • Capacity additions and competitive intensity: Industry capacity cycles can lead to margin compression if demand growth lags supply.
  • Operational and environmental compliance: Manufacturing downtime, quality incidents, and environmental compliance costs can affect earnings and customer trust.

📊 Valuation & Market View

Markets typically value specialty ingredients companies on earnings power durability rather than on growth alone. Common valuation frameworks include:
  • EV/EBITDA: driven by operating margin quality, utilization, and normalized earnings stability.
  • P/E: influenced by cyclicality perception, input-cost pass-through, and capital intensity expectations.
  • EV/Revenue (less favored): used when investors focus on resilience of revenue streams and service-level delivery, though margins ultimately dominate.
Drivers that tend to move valuation include: sustained specialty mix, evidence of pricing discipline during cost cycles, credible capital allocation, and improvements in manufacturing efficiency and working-capital management.

🔍 Investment Takeaway

Ingredion’s long-term attractiveness rests on customer qualification-driven switching costs and application-led differentiation within starches, sweeteners, and nutrition-related specialty ingredients. The company’s moat is reinforced by manufacturing scale and global service reliability, which together can help sustain share and protect margins through commodity cycles—while growth is supported by the ongoing shift toward higher-value functional ingredient applications.

⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for INGR.

seekingalpha.com2026-06-08

Ingredion Incorporated (INGR) M&A Call Transcript

Ingredion Incorporated (INGR) M&A Call Transcript

feeds.benzinga.com2026-06-08

Stock Market Today: Dow Jones Futures Fall, S&P 500 Gains As Israel, Iran Exchange Missile Strikes—SK Telecom, Nebius, AMD In Focus

U.S. stock futures were mixed on Monday, as the Nasdaq 100 and S&P 500 indices gained, and the Dow Jones index fell, following Thursday's sharp declines.

wsj.com2026-06-08

Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal

Ingredion offered the equivalent of $7.94 for each Tate & Lyle share, a 59% premium to the last closing price before takeover talks were disclosed last month.

globenewswire.com2026-06-08

Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle

Creates a scaled global provider of specialty ingredient solutions for a healthier, tastier and more sustainable future of food  Broadens Ingredion's specialty ingredients platform across texturants, sugar reduction, and fortification, adding complementary capabilities in multi-ingredient systems and recipe development Expands Ingredion's ability to address customer needs across a wider range of end use categories and applications Brings together complementary geographic supply networks across the Americas, Europe, the Middle East and Africa, and Asia Pacific to deliver faster, more reliable and cost-effective ingredients and solutions for customers and consumers worldwide WESTCHESTER, Ill., June 08, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR) (“Ingredion”), a leading global provider of ingredient solutions to the food and beverage and industrial segments, today announced a recommended all-cash offer for the acquisition of Tate & Lyle PLC (“Tate & Lyle”), a global leader in mouthfeel, sweetening and fortification (the “Acquisition”).

reuters.com2026-06-08

UK's Tate & Lyle agrees $3.6 billion Ingredion takeover

Britain's Tate & ​Lyle ‌has agreed to ​a £2.7 ​billion ($3.60 billion) ⁠offer ​from U.S. ​rival Ingredion , the ​companies ​said on Monday, ‌creating ⁠a food and ​beverage ​ingredients ⁠major.

globenewswire.com2026-06-02

Ingredion acquires Benicaros® -- a prebiotic fiber that supports immune health at extremely low daily dosage/intake

WESTCHESTER, Ill. , June 02, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for the food, beverage and industrial markets, announced the acquisition of Benicaros, a patented, prebiotic fiber made from upcycled carrot pomace clinically shown to support immune health.

globenewswire.com2026-06-02

Ingredion acquires Benicaros® -- a prebiotic fiber that supports immune health at extremely low daily dosage/intake

WESTCHESTER, Ill., June 02, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for the food, beverage and industrial markets, announced the acquisition of Benicaros®, a patented, prebiotic fiber made from upcycled carrot pomace clinically shown to support immune health.

globenewswire.com2026-05-28

Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India

WESTCHESTER, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage, pharma and industrial markets, announced a joint venture with Sanstar Limited and an equity stake in Sanstar, India's leading manufacturer of corn-based specialty products.

globenewswire.com2026-05-28

Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India

WESTCHESTER, Ill. , May 28, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage, pharma and industrial markets, announced a joint venture with Sanstar Limited and an equity stake in Sanstar, India's leading manufacturer of corn-based specialty products.

globenewswire.com2026-05-27

Ingredion Achieves 96.3% Sustainable Sourcing of Tier 1 Priority Crops, Up From 25% Just Five Years Ago

WESTCHESTER, Ill. , May 27, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading provider of ingredient solutions, announced a new milestone, more than 96% of its tier 1 priority crops are now sustainably sourced. "Five years ago, sustainable sourcing for corn, tapioca, potato, stevia and pulses measured just 25%," said Larry Fernandes, senior vice president, chief commercial and sustainability officer.

globenewswire.com2026-05-27

Ingredion Achieves 96.3% Sustainable Sourcing of Tier 1 Priority Crops, Up From 25% Just Five Years Ago

WESTCHESTER, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading provider of ingredient solutions, announced a new milestone, more than 96% of its tier 1 priority crops are now sustainably sourced.

wsj.com2026-05-21

Ingredion Takeover Target Tate & Lyle Posts Fall in Profit

The British ingredients company reported lower profit for what it called a disappointing fiscal year.

globenewswire.com2026-05-20

Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share

WESTCHESTER, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, announced today that its board of directors declared a quarterly dividend of $0.82 per share on the Company's common stock.

seekingalpha.com2026-05-18

Ingredion: Oversold After Argo Issues, Acquisition Could Change The Story

Ingredion Incorporated (INGR) remains a Buy, supported by strong financials and robust cash generation despite recent operational setbacks and macro pressures. Q1 results were weak due to Argo facility issues, leading to reduced 2026 guidance and highlighting operational and cost risks. Potential acquisition of Tate & Lyle could transform INGR, expanding geographic reach significantly and helping to diversify into higher-growth segments.

wsj.com2026-05-14

Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer

The proposed offer value is a 64% premium to the London-listed food-and-beverage ingredient company's closing share price Wednesday.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Headline (2026-03-31, Q1): Revenue $1.792B; Net Income $142M; EPS $2.36. QoQ (vs 2025-12-31): Revenue +2.0%, Net Income -13.9%, EPS -8.9%. YoY (vs 2025-03-31): Revenue +1.6%, Net Income -28.0%, EPS -22.6%. Across the last four quarters, top-line has been broadly flat to slightly down sequentially (Q2→Q1 peaked in 2025 then eased in 2026), while profitability has clearly deteriorated: gross margin fell from ~25.7% (2025-03-31) and ~26.0% (2025-06-30) to 22.4% in 2026-03-31; net margin compressed to 7.9% from 10.9% a year ago. Operating income and EBITDA also declined versus earlier quarters, signaling margin pressure rather than demand collapse. Cash flow weakened materially in the most recent quarter: operating cash flow was only $33M and free cash flow was -$77M, driven by a large working-capital outflow. Balance sheet remains resilient for an industrial, with total assets ~ $7.93B and equity ~ $4.42B; leverage (net debt ~$0.91B) is manageable and interest coverage remains strong (~22x). Shareholder returns: the stock is down ~10.0% over 1 year (price momentum negative). Dividend yield is ~0.7%, and buybacks were modest (repurchased ~$14M in the quarter), so total shareholder return outlook is constrained by weaker earnings power. Analyst/valuation context: consensus target median is ~$117 vs $115.25 current, implying limited upside (and the valuation multiples appear supported but cash-flow metrics remain pressured)."

Revenue Growth

Neutral

Revenue was $1.792B in Q1 2026, up +2.0% QoQ but only +1.6% YoY, indicating largely flat demand with no clear acceleration.

Profitability

Neutral

Net income fell -13.9% QoQ and -28.0% YoY. Margins compressed materially: net margin to 7.9% from 9.4% in Q4 and 10.9% in Q1 last year; gross margin down to 22.4% from ~25.7% a year ago.

Cash Flow Quality

Neutral

Operating cash flow was only $33M and free cash flow was -$77M in the most recent quarter, with working-capital outflow (-$184M). This weakens the earnings-to-cash conversion versus prior quarters.

Leverage & Balance Sheet

Positive

Total assets were ~ $7.93B with equity ~ $4.42B (stable). Interest coverage remains strong (~22x). Net debt is ~$0.91B; balance sheet resilience supports ongoing dividends/buybacks.

Shareholder Returns

Caution

1-year price change is -10.0% (negative momentum). Dividend yield is ~0.7% and buybacks were relatively small in Q1 ($14M), so total return is not being driven by capital gains.

Analyst Sentiment & Valuation

Positive

Consensus median target (~$117) is modestly above the current price (~$115.25). However, cash-flow multiples look less favorable (FCF negative in the latest quarter), tempering forward expectations.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

INGR’s Q1 2026 results were pressured by a major operational disruption at the Argo facility in Food & Industrial Ingredients U.S./Canada and by FX/volume softness in LatAm. Net sales declined 1% to $1.8B and adjusted operating income fell 22% YoY to $212M, with gross margin dropping to 22.4%. Argo costs escalated to about $40M versus a $10M–$15M expectation, including elevated rework and logistics sourced from other plants; a second issue on April 10 (thermal event in corn germ processing) is expected to normalize unit operations within Q2. Despite macro uncertainty, Texture & Healthful Solutions delivered continued momentum: eighth straight volume growth (+2%) and strong healthful/clean-label product growth (pea protein isolates +50%+, stevia solutions +6%). Management updated 2026 guidance modestly negatively (net sales flat to low single digit; adjusted operating income flat to down low single digits) and reiterated a mid-teens operating margin aspiration for U.S./Canada with recovery targeting 2027.

AI IconGrowth Catalysts

  • Texture and Healthful Solutions eighth straight quarter of volume growth (+2%), led by Clean Label and Texture Solutions in EMEA and Asia Pac
  • Functional native starches grew strongly on demand for simpler ingredient panels and reformulation support
  • Pea protein isolates from recent product innovations grew >50% in the quarter
  • Clean-tasting stevia-based solutions grew +6% in the quarter
  • Healthful solutions growth supported by sugar reduction and protein fortification; solutions sales ~1.0B or ~40% of segment revenue
  • AI-enabled consumer insights and predictive formulation accelerating the brief-to-solution cycle time

Business Development

  • Customer co-development/co-creation via formulation expertise; differentiation through co-development and deeper customer engagement
  • Use of 30+ Idea Labs globally and a technical headquarters in Bridgewater, New Jersey to support solution briefs and co-packing ecosystems
  • Partnering with co-packing networks and private label ecosystem; increasing pipeline of project briefs to shorten delivery cycles

AI IconFinancial Highlights

  • Q1 net sales: $1.8B, down 1% YoY; adjusted operating income down 22% YoY to $212M
  • Gross margin: 22.4% (down); gross profit declined 14% driven by Argo operational challenges, lower volumes/unfavorable mix in U.S./Canada and LatAm, and Mexico transactional FX
  • Earnings bridge: adjusted diluted EPS declined by $0.63 YoY, including $0.71 of margin impacts and $0.14 of volume impacts; partially offset by $0.07 FX translational benefits, $0.08 other income, and $0.07 nonoperating items including $0.06 share repurchase benefits
  • Argo impact: Feb outlook expected $10M–$15M additional costs; actual Q1 impact increased to ~$40M (higher maintenance spend + elevated rework); downstream returned to normal levels by quarter end after process failures
  • Argo event: April 10 isolated thermal event in corn germ processing; crude oil production offline; expected normal operations in that unit within Q2
  • Margin decline reference: management cited ~1,000 bps of margin decline in the quarter vs the business’ typical 16%–17% operating margin profile

AI IconCapital Funding

  • Q1 capital allocation: $52M dividends plus $14M share repurchase
  • Cash flow: year-to-date cash from operations $33M; driven by planned $205M working-capital investment (receivables/payables)
  • Capital expenditures: $110M net of disposals in Q1
  • Full-year CFFO guidance (updated): $725M–$825M
  • Full-year CapEx guidance (unchanged): $400M–$440M
  • No explicit debt level disclosed in transcript; financing cost estimate for 2026: $35M–$45M

AI IconStrategy & Ops

  • Food & Industrial Ingredients LatAm: announced plan to cease operations at Cabo manufacturing facility in Northeast Brazil by end of Q2 as part of enterprise productivity/network optimization and sharpening customer mix priorities
  • Brazil recovery support: improved customer demand and early benefits from polyols network optimization completed end of last year
  • Argo actions: assembled multidisciplinary internal/external team; downstream returned to normal by quarter end; repairs underway for germ processing unit
  • Supply chain posture: continued localization to mitigate sourcing disruption risk; monitoring energy/logistics impacts and packaging inflation

AI IconMarket Outlook

  • Updated full-year 2026: net sales flat to up low single digits; adjusted operating income flat to down low single digits
  • Adjusted EPS (full-year 2026): $10.45–$11.15 (diluted share count 63.5M–64.5M)
  • 2026 effective tax rate: 26%–27.5% (reported and adjusted); 2026 financing cost: $35M–$45M
  • 2026 cash from operations: $725M–$825M; working-capital investments assumed in line with normalized inventory
  • Q2 2026: net sales flat to up low single digits; adjusted operating income down high single digits (lapping a strong Q2 2025)
  • Guidance includes tariff levels in effect at end of April 2026; excludes acquisition integration/restructuring and any potential impairment costs
  • Segment operating outlook: Texture & Healthful Solutions operating income now expected up low single digits; Food & Industrial Ingredients LatAm net sales flat to down low single digits with operating income down low single digits; Food & Industrial Ingredients U.S./Canada operating income projected down low double digits with net sales down low single digits

AI IconRisks & Headwinds

  • Argo operational risk: Q1 $40M cost impact vs $10M–$15M outlook due to slower-than-expected recovery and elevated rework; April 10 thermal event in corn germ processing expected recovery within Q2
  • Margin pressure from raw material timing: rapid rise in tapioca costs in Asia Pac began end of Q4 2025; pass-through typically takes ~1–1.5 quarters, contributing to Q1 pricing/margin lag
  • Transactional FX: Mexico peso strength is a “meaningful” transactional foreign exchange headwind for F&II LatAm; management notes pesos for SG&A/operating costs vs U.S. dollar denominated Mexico business
  • Energy/logistics cost inflation: higher energy prices driving increased logistics costs; management expects to offset via in-year price increases but is monitoring indirect demand effects
  • Consumer demand uncertainty in 2H tied to cost pass-through (packaging inflation mid-single to high-single digits and gasoline impacts)
  • LatAm volume uncertainty: cautious outlook for remainder of 2026 Mexico volumes; brewery volumes lower due to conservative customer ordering ahead of World Cup; lapping prior-year softness in Q3 related to a customer contract management issue

Q&A: Analyst Interest

  • Argo margin and timing to mid-teens: Management reiterated commitment to returning U.S./Canada to the mid-teens operating margin profile, explaining Argo as the predominant cause. They described the April 10 germ-processing issue as isolated and expected within Q2, with confidence to recover the majority of ~1,000 bps decline by 2027 if reliability stabilizes.
  • Texture & Healthful growth math (FX vs organic and pricing): Analysts asked how the segment progresses from Q1’s ~flat organic growth (2% volume driven largely without pricing support) to the low-to-mid single digit target. Management emphasized solutions-led growth, resegmentation, trainings/certifications, co-creation via Idea Labs, regulatory-driven reformulations, and pipeline/project briefs accelerating faster delivery as macro normalizes.
  • Cost pass-through and elasticity in a tougher macro: Management discussed ability to pass through most direct costs contractually, citing prior tariff navigation where net impact was ~+$6M. They flagged indirect impacts as the bigger risk—consumer demand effects from packaging inflation and gasoline-driven affordability—while noting minimal-to-no impact observed in Q1 so far.

Sentiment: MIXED

Note: This summary was synthesized by AI from the INGR Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for INGR.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (INGR)

© 2026 Stock Market Info — Ingredion Incorporated (INGR) Financial Profile